Agilis Biotherapeutics Announces Orphan Designation Approval in Europe for the Treatment of Angelman Syndrome Biotech Investing
Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11 Biotech Investing
Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies Biotech Investing
Gelesis Announces Positive Safety Data from First-In-Human Study of Second Product Candidate, Gelesis200 Biotech Investing
Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine Biotech Investing
Stemline Therapeutics Clears First Cohort of Patients in Ongoing SL-801 Phase 1 Trial Biotech Investing
Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population Biotech Investing
Naturally Splendid: A Leader in the Science of Hemp and Omega-based Product Development Biotech Investing
Ignyta Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares Biotech Investing
